1. 北京中医药大学循证医学中心
2. 中国中医药出版社
3. 北京市东城区第一人民医院
纸质出版:2020
移动端阅览
[1]张雅静,曹卉娟,刘建平,李欣霖,谢占国.考虑患者偏好的部分随机对照试验的文献计量学研究[J].中医杂志,2020,61(05):442-448.
ZHANG Yajing, CAO Huijuan, LIU Jianping, et al. Bibliometric Study on Partial Randomized Controlled Trials Considering Patients′ Preference[J]. Journal of Traditional Chinese Medicine2020, 61(5): 442-448.
[1]张雅静,曹卉娟,刘建平,李欣霖,谢占国.考虑患者偏好的部分随机对照试验的文献计量学研究[J].中医杂志,2020,61(05):442-448. DOI: 10.13288/j.11-2166/r.2020.05.016.
ZHANG Yajing, CAO Huijuan, LIU Jianping, et al. Bibliometric Study on Partial Randomized Controlled Trials Considering Patients′ Preference[J]. Journal of Traditional Chinese Medicine2020, 61(5): 442-448. DOI: 10.13288/j.11-2166/r.2020.05.016.
目的采用文献计量学研究方法总结既往发表的考虑患者意愿的部分随机对照试验(PRPP)研究的特征
为中医非药物疗法的临床试验方法学提供参考。方法检索中国知网、维普网、万方数据知识平台、PubMed、Cochrane图书馆数据库
纳入从建库至2019年4月30日发表的PRPP研究。采用Excel 2010设计资料提取表对纳入研究进行资料提取
并对定量资料进行趋势分析与频数分析。结果共纳入42项PRPP研究
研究数量逐年增长并在2009年达到高峰(6篇)。应用PRPP最多的前四类疾病为妊娠、分娩和产褥期疾病12篇(28.57%)
肿瘤6篇(14.29%)
消化系统疾病6篇(14.29%)以及精神和行为障碍类疾病如抑郁6篇(14.29%)。研究总样本量范围为31~5231例
平均样本量598例;随机组与意愿组样本量之比平均值为1∶1.12。纳入研究中共17项(40.48%)采用随机对照试验样本量计算方法。对照类型中位列前3的是不同非药物疗法之间的比较(21项
50.00%)、药物与非药物疗法之间的比较(11项
26.19%)和不同用药途径的比较(5项
11.90%)。结局指标的选择位列前3的为疗效评价指标(78.57%)、患者意愿(26.19%)和患者满意度(14.29%)。结论现有的PRPP大多应用于非药物疗法的评价
涉及疾病也常见于手术等非药物治疗的类型。
Objective The bibliometric method was used to summarize the characteristics of the previously published partial randomized controlled trial(PRPP) studies that considered the patient′s willingness
and to provide a reference for the clinical trial methodology of traditional Chinese medicine non-drug therapy. Methods CNKI
VIP Net
Wanfang Data Knowledge Platform
PubMed
and Cochrane Library databases were searched on PRPP study published from the establishment of the database to April 30 th
2019. Excel 2010 was used to design the data extraction table to extract data from the included studies
and quantitative analysis was performed for trend analysis and frequency analysis. Results A total of 42 PRPP studies were included
and the number of studies increased year by year and reached a peak in 2009(6 articles). The top 4 diseases with the most PRPP application are pregnancy
childbirth and puerperal diseases(12 articles 28.57%)
tumors(6 articles
14.29%)
digestive diseases(6 articles
14.29%)
and mental and behavioral disorders such as depression(6 articles
14.29%). The total sample size ranged from 31 to 5231
with an average sample size of 598 cases. The average ratio of randomization and preference group is 1 ∶1.12. In the included studies
a total of 17 items(40.48%) use the method of calculating the sample size of randomized controlled trials. The top 3 control types were comparisons between different non-drug therapies(21 items
50.00%)
comparisons between drugs and non-drug therapies(11 items
26.19%)
and comparisons of different medication routes(5 items
11.90%). The top 3 outcome indicators were efficacy evaluation indicators(78.57%)
patient willingness(26.19%)
and patient satisfaction(14.29%). Conclusion Most of the existing PRPPs are used in the evaluation of non-pharmacological therapies
and the diseases involved are also common in the types of non-pharmacological treatments such as surgery.
0
浏览量
290
下载量
3
CSCD
关联资源
相关文章
相关作者
相关机构
京公网安备11010102007558号